Case 5A: Everted Papilloma

A 28 year old female was seen with complaints of left-sided nasal obstruction. The CT scan showed a hypodense mass in the left nasal cavity attached to the septum and left lateral nasal wall with collection in the left ethmoid and frontal sinuses.

The diagnostic nasal endoscopy showed some interesting findings. On primary inspection it resembled a nodular stage of rhinoscleroma, but on suctioning the mass exposed multiple papillae which comprised the mass. The mass was removed by endoscopic approach.

Figure 1: Intranasal Appearance of an Everted Papilloma Click on Pictures to Enlarge

Figure 2: Coronal CT Scan of an Everted Papilloma Click on Pictures to Enlarge

The histopathology showed multiple complex branching patterns having fibrovascular, core-typifying exophytic patterns. Papillae were lined by multilayered epithelium that contained both squamoid and transitional epithelium with occasional mucoytes. Fibrous stroma showed mononuclear infiltration.

Figure 3: Histological Appearance Click on Pictures to Enlarge


Modha Nu Cancer  (English Version)

Dhumrapan thi sauthi vadhre jokham modha na cacer thava nu che.  Daru ane dumrapan sathe karvathi galanu, swarpeti nu, modha nu and ann nali nu cancer thava nu jokham vadhare vadhi jaay che.American society ni aankadakiya mahiti pramne 28,000 nava dardi ane 7,400 maran modhana and gala na cancer thi nondhayela che.

Gala na cancer na dardi je dhumrpan kare che tene aa cancer lasika granthi temaj aagal phelava ni shakyata vadhare raheli che. Jovo Article Ni Nondh

Niche nu chitra New Mexico Dept of Health na dardi nu che jene"jadba-jibh-gala na cancer ni sarvar kareli che. Operaion and kirno no shek aathvato kirno no shek and chemotherapy ni sarvar vadhare swikrut che.

Jamni baju nu chitra ae dardi nu che jeni jadba jibh and gala nu operation thayu che. Hoth ne kapava ma aavyo che ane gala ni chamdi and gaal uncha karvama aavya che.Jadbu, jibh , gala no bhag and talvu tyare kadhi shakay che. *** Chitra ne motu karva mate click karo ***

Jamni baju nu chitra operation thi kadhi nakhelo bhaag che. *** Chitra ne motu karva mate click karo ***

Sarvar karva chata ghana cancer pacha thai sake che. aava dardi ma cancer tena gala moti kharba sathe ni gaanth ni jem thay che.  Aa ganth dhire dhire moti dhamni ne khay ne vadhre lohi vahave che and ochintu mrityu thai shake che.

Betahistine Helps Turkey Oncologist with His Meniere's Symptoms.

Meniere's disease is recognized as the idiopathic form of recurrent inner ear disease with the triad of fluctuating hearing loss, tinnitus and vertigo (1).  There is no generally accepted tratment strategy for the disease. Betahistine dihydrochloride is recommended as first choice medical treatment and in case of failure in medical treatment and if hearing is worth saving, endolymphatic shunt surgery can be employed (2).  I am a 36 year-old-pediatric oncologist and I have been followed with the diagnosis of Meniere's disease for 13 years. At the time of diagnosis I had serious vertigo attacks lasting 4-24 hours, tinnitus and bilateral hearing loss at low frequencies. After 6 months treatment of betahistine dihydrochloride and low-salt diet, the hearing loss was relieved.  For 9 years I have experienced 1-2 vertigo attacks per year which were controlled with diphenhydramine and diuretics in acute attack and betahistine dihydrochloride three 16 mg at least 3 months.

For the last four years I have started myself a schedule consisting of betahistine dihydrochloride 8 mg/day resembling metronomic therapy which is a well-known practice in cancer treatment.  I have experienced no vertigo attacks, nor have tinnitus or hearing difficulty for 4 years.  All audiometric test results made once a year were normal during this period.  No side effects developed related with the medication.  Betahistine dihydrochloride is an orally administered, centrally acting histamine H1 receptor agonist with partial H3 antagonistic activity.  It was clinically studied and is still used mainly as a vasodilator for the treatment of Meniere's disease (3).  Its proposed mode of action is to cause vasodilation in ischemic areas of the stria vascularis and dark cells in the areas implicated in the pathogenesis of Meniere's disease (4).  Strupp et al. (5) have found that the number of attacks after 12 months was significantly lower in the high dosage group (48 mg tid, n=62) than in the low dosage group (16 mg tid, n=21, 24 mg, n=29) with betahistine dihydrochloride therapy. Taking the medication in a metronomic fashion may regulate the circulation in affected areas continuously. No serious adverse effects was reported with long-term or high dose administration of betahistine dihydrochloride. Prospective clinical studies with adequate numbers of patients will reveal the efficiency of this metronomic therapy with continuous low-dose betahistine dihydrochloride in treatment of Menière's disease.


1. Minor LB, Schessel DA, Carey JP. Ménière's disease. Curr Opin Neurol. 2004 Feb;17(1):9-16.   View Abstract

2. Westhofen M. [Article in German] [Menière's disease : evidence and controversies] HNO. 2009 May;57(5):446-54.   View Abstract

3. Barak N. Betahistine: what's new on the agenda? Expert Opin Investig Drugs. 2008 May;17(5):795-804.   View Abstract

4. Phillips JS, Prinsley PR. Prescribing practices for Betahistine. Br J Clin Pharmacol. 2008 Apr;65(4):470-1. Epub 2008 Feb 12.   View Abstract

5. Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K, Zingler VC, Mansmann U, Brandt T. Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 2008 May;128(5):520-4.  View Abstract

Serhan Kupeli
Chief of Pediatric Oncology Unit
Diyarbakir Children's Diseases Hospital
Diyarbakir, Turkey

Editor in Chief: Sudhakar Vaidya, DNB(ENT) DLO, India View CV 1

India Editorial Board -- About Review Board - Resumes

- Vikas Sinha, MS (India) View CV 2

- P. S. N. Murthy, MS (India) View CV 1,5

- Anirban Biswas, MS Neurotology (India) View CV 3,4

- Ajay Kumar Jain, MS (India) View CV 1

- Abhoya Kar, MS (India) View CV 6

- Jayant Watve, MS (India) View CV

- Gauri Mankekar, MS, DNB, PhD (India)

- Apurva Motiramiji Pawde View CV

- Ashok Kumar Gupta View CV

- Milind V Kirtane, MS (India)

- Achal Gulati, MS (India)

- Vasim Modak MS (KSA - India)

Mid-East Section Editor:

Ahmed Saada, MD, Egypt View CV

Mid-East Editorial Board About Review Board - Resumes

- Essam Saleh, MD - Saudi Arabia View CV

- Hossam Talaat, MD Audiology - Egypt View CV

- Ahmed Hesham, MD - Oman

- Hussain Abdul Rahman, MS - U.A.E.

- Khaled Salem Mesalaty, MD - Libya View CV

- Mohammed Kamel, FRCS - Saudi Arabia

- Hazem Sadir MD - Syria View CV

- Odabasi Onur MD - Turkey

Europe and Eastern Europe Section Editor:

Milan Stankovic, MD, Serbia View CV

Europe & Eastern Europe Editorial Board About Review Board - Resumes

- Manuel Oliva Dominguez (Spain) View CV

- David Bakhos (France) View CV

- Enache Oana-Gabriela (Romania)

United States, Canada, Australia Section Editor

John Houck, MD USA View CV

USA, Canada, Australia Editorial Board About Review Board - Resumes

- Jerome Thompson, MD (USA) View CV 1

- Steve Wetmore, MD (USA) View CV 1

- Kevin T Kavanagh, MD (USA) View CV

- William Pao, MD (USA) View CV

- Neal Beckford, MD (USA) View CV

- Peter Friedland, MD (Australia) View CV

1. ENT Department Chairman (Head)

2. Dean and ENT Professor

3. Editor Journal of the Indian Society of Otology

4. Past Editor of the Indian Journal of Otolaryngology and Head and Neck Surgery

5. Editor Indian Journal of Otolaryngology and Head and Neck Surgery

6. Editor Orissa Journal of Otolaryngology & HNS

Editorial Team

1. Surabhi Naik

2. Priyanka Patel

3. Rushil Puri

4. Dhaval Bhojani

5. Sameeksha Mishra

6. Riya Jain

7. Pushpendra Patel

8. Suryakant Sharma

 Video Consultation and Editing: Keshav Deshpande

Statistics Consultant: David Walonick, statistics Professor University of St Thomas in St Paul MN

Dharmpal Chauhan, Statistics Professor R.D Gardi Medical College, Ujjain, India

Publisher: Department of ENT & Head-Neck Surgery, R.D Gardi Medical College, Ujjain, India  

Letters-To-The-Editor (LTTE) View Letters

A maximum of 2500 characters may be submitted utilizing an online form.

Go To LTTE Submission Page

Indian Translation Section

The information in this site is provided for educational purposes only, and is not intended to be a substitute for a physician consultation. Please consult your own physician about any opinions or recommendations with respect to your own medical condition and symptoms.

( Site Map )

This site complies to the HONcode standard for trustworthy health information: verify here.

ISSN 1948-9579

WAENT, ENT USA, Cumberland Otolaryngology or Dr Kevin Kavanagh, MD do not endorse, recommend, refer to or are responsible for the content and claims made by authors or advertisers seen in WAENT and ENTUSA. 
Always consult a qualified physician for recommendations for diagnosis and treatment of medical conditions.

DMCA Complaints:  Digital Millennium Copyright Act.  All complaints are taken seriously and will be investigated.  To file a copyright infringement notice please go to: 
 FILE DMCA Complaint

View Editorial Review Board